RIPK1激酶结构域基因抑制减少小鼠脑出血后细胞死亡并改善功能结局
本研究利用RIPK1激酶结构域点突变(K45A和D138N)失活的小鼠,在自体血脑出血模型中观察急性细胞死亡和功能结局。结果显示突变小鼠质膜通透性细胞减少、急性神经元死亡减少、体重恢复更快且Morris水迷宫表现改善;全身给予RIPK1抑制剂GSK'963也减少出血后24小时急性神经元死亡。结论提示RIPK1激酶结构域是脑出血的疾病驱动因素,支持开发RIPK1抑制剂用于人类脑出血治疗。
要点
- RIPK1激酶结构域基因失活可减少脑出血后急性神经元死亡。
- RIPK1激酶失活改善脑出血后体重恢复和Morris水迷宫功能结局。
- 特定RIPK1抑制剂GSK'963减少脑出血后24小时急性神经元死亡。
核心结论
- RIPK1激酶结构域是脑出血的疾病驱动因素,介导急性细胞死亡和功能结局。
- 数据支持开发RIPK1抑制剂作为人类脑出血的治疗药物。
研究设计与样本
- 研究使用两种RIPK1激酶结构域点突变(K45A和D138N)失活小鼠品系。
- 小鼠接受自体血脑出血模型,测量急性细胞死亡和功能结局。
主要发现
- 与野生型对照相比,RIPK1K45A/K45A和RIPK1D138N/D138N小鼠质膜通透性细胞显著减少。
- 突变小鼠急性神经元细胞死亡减少,体重丢失减少且恢复至基线更快。
- 突变小鼠在自体血脑出血后Morris水迷宫表现改善。
- 全身给予GSK'963(强效、特异性、脑渗透性小分子RIPK1抑制剂)的小鼠脑出血后24小时急性神经元死亡减少。
局限性
- 既往使用化学抑制剂的研究存在脱靶效应,不能单独证明RIPK1的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Recent studies using cultured cells and rodent intracerebral hemorrhage (ICH) models have implicated RIPK1 (receptor interacting protein kinase-1) as a driver of programmed necrosis and secondary injury based on use of chemical inhibitors. However, these inhibitors have off-target effects and cannot be used alone to prove a role for RIPK1. The aim of the current study was to examine the effect of genetic inhibition of the kinase domain of RIPK1 in a mouse ICH model. METHODS: We subjected 2 lines of mice with RIPK1 point mutations of the kinase domain (K45A and D138N), rendering them kinase inactive, to autologous blood ICH and measured acute cell death and functional outcome. RESULTS: Compared with wild-type controls, RIPK1K45A/K45A and RIPK1D138N/D138N had significantly less cells with plasmalemma permeability, less acute neuronal cell death, less weight loss and more rapid weight gain to baseline, and improved performance in a Morris water maze paradigm after autologous blood ICH. In addition, mice systemically administered GSK'963, a potent, specific, brain penetrant small molecule RIPK1 inhibitor, had reduced acute neuronal death at 24 hours after ICH. CONCLUSIONS: The data show that the kinase domain of RIPK1 is a disease driver of ICH, mediating both acute cell death and functional outcome, and support development of RIPK1 inhibitors as therapeutic agents for human ICH.
引用
- Lule S, Wu L, McAllister LM, et al. Genetic Inhibition of Receptor Interacting Protein Kinase-1 Reduces Cell Death and Improves Functional Outcome After Intracerebral Hemorrhage in Mice. Stroke. 2017. PMID: 28765287. doi:10.1161/STROKEAHA.117.017702
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。